Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia

Author： Kumar Rajnish   Malla Priyanka   Kumar Manoj  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.8, 2013-11, pp. : 1013-1027

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia

By  

Current Medicinal Chemistry, Vol. 13, Iss. 28, 2006-12 ,pp. : 3395-3416

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment options for benign prostatic hyperplasia

By Thurlow R.J.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 225-246

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride for the treatment of benign prostatic hyperplasia

By Wu Christopher   Kapoor Anil  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1399-1408

Informa Healthcare

Access to resources Recommend Favorite

NX 1207 is promising for the treatment of benign prostatic hyperplasia

By  

Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Treatment of Benign Prostatic Hyperplasia in Patients with Cardiovascular Disease

By Santillo Vincent M.   Lowe Franklin C.  

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 795-805

Adis International

Access to resources Recommend Favorite